Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93492402 | 9349240 | 2 | F | 20160721 | 20130614 | 20160721 | EXP | IR-BRISTOL-MYERS SQUIBB COMPANY-19012095 | BRISTOL MYERS SQUIBB | 14.00 | YR | M | Y | 52.00000 | KG | 20160721 | OT | IR | IR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93492402 | 9349240 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 5 MG, QD | 9218 | 5 | MG | QD | |||||||
| 93492402 | 9349240 | 2 | I | CLOXACILLIN | CLOXACILLIN | 1 | Unknown | DOSE INCREASED TO 10MG | 0 | 2 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93492402 | 9349240 | 1 | Product used for unknown indication |
| 93492402 | 9349240 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93492402 | 9349240 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93492402 | 9349240 | Coagulation time shortened | |
| 93492402 | 9349240 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |